Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system Health Condition 2: M479- Spondylosis, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who are reported with the following indicators (referred with diagnosis) describe their complaints. As per the International Statistical Classification of Diseases and Related Health Problem (ICD) Codes 76 Acute and Sub Acute Low Back Pain with Mobility Deficits M99.0: Lumbosacral segmental/somatic dysfunction Acute, Sub Acute, and Chronic Low Back with Movement Coordination Impairments M53.2: Spinal instabilities Acute Low Back Pain with Related (Referred) Lower Extremity Pain M40.3: Flatback syndrome M51.2: Other specified intervertebral disc displacement (Lumbago due to displacement of the intervertebral disc) Acute, Sub Acute, and Chronic Low Back Pain with Radiating Pain M54.1: Lumbar radiculopathy (neuritis or radiculitis) M54.4: Lumbago with sciatica
Exclusion criteria
Exclusion criteria: Acute or Sub Acute Low Back Pain with Related Cognitive or Affective Tendencies M54.5: Low back pain G96.8: Disorder of central nervous system, specified as central nervous system sensitivity to pain Chronic Low Back Pain with Related Generalized Pain F45.4: Persistent somatoform pain disorder Chronic Low Back Pain with Related Generalized Pain Back related tumor Cauda equina syndrome Back related infection Spinal compression fracture Abdominal aneurysm ( >4cm) spinal fractures prolonged use of corticosteroids. older than 70 years old the patient’s clinical findings are suggestive of serious medical or psychological pathology, progressive neurological deficits clinical anxiety and depression (such patients presenting yellow flag) 76
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain Catastrophizing Scale (PCS) The Örebro Musculoskeletal Pain Questionnaire (cut-off score) (OMPQ) Return to work efficacy scale (RTW-SE) 91 Back-paq 20 item scale (BACK-PAQ) Implicit Association test with PHODA-SeV Protectometer Patient-specific functional scale (PSFS) EXAS SIRAS Timepoint: at 1st session, 2nd session and 3rd session of therapy. After 3 months, 6, months, 1 year of Follow Up | — |
Secondary
| Measure | Time frame |
|---|---|
| naTimepoint: na | — |
Countries
India
Contacts
Maharashtra university of health sciences, Nasik